https://blog.globalregulatoryaffairs.co/invima-actualiza-manual-tarifario-para-usuarios-del-sector-salud/2024-02-14T19:48:54+00:00https://blog.globalregulatoryaffairs.co/situacion-de-radiofarmacos-en-colombia-sin-desabastecimiento-a-la-vista/2024-08-28T17:41:22+00:00https://blog.globalregulatoryaffairs.co/nueva-base-de-calculo-para-sanciones-del-invima-impacto-en-el-sector-regulado/2025-06-17T15:29:13+00:00https://blog.globalregulatoryaffairs.co/invima-propone-modernizar-tramites-sanitarios-para-alimentos-como-afecta-a-tu-empresa/2025-06-17T15:37:20+00:00https://blog.globalregulatoryaffairs.co/regulacion-de-compras-farmaceuticas-oportunidad-o-riesgo-para-la-industria-nacional/2025-07-11T16:37:59+00:00https://blog.globalregulatoryaffairs.co/colombia-en-el-penultimo-lugar-en-competitividad-biofarmaceutica-retos-y-oportunidades-para-el-sector/2025-07-11T16:35:51+00:00https://blog.globalregulatoryaffairs.co/revolucion-regulatoria-como-la-ia-de-la-fda-transformara-la-industria-farmaceutica/2025-07-11T16:27:57+00:00